{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:18:33Z","timestamp":1784798313580,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007565","name":"Consumers, Health, Agriculture and Food Executive Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014028","name":"Horizon 2020","doi-asserted-by":"publisher","award":["801520 - HP-JA-2017"],"award-info":[{"award-number":["801520 - HP-JA-2017"]}],"id":[{"id":"10.13039\/100014028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejso.2021.08.018","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T11:50:53Z","timestamp":1630151453000},"page":"967-977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7330-6308","authenticated-orcid":false,"given":"Josep M.","family":"Borras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7538-4809","authenticated-orcid":false,"given":"Riccardo","family":"Audisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4027-7114","authenticated-orcid":false,"given":"Josep Alfons","family":"Espinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Figueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-0422","authenticated-orcid":false,"given":"Peter","family":"Naredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Panteli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pourel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Prades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2021.08.018_bib1","series-title":"Purchaising to improve health systems performance","article-title":"Purchasing to improve health systems performance: drawing the lessons","author":"Figueras","year":"2005"},{"issue":"1","key":"10.1016\/j.ejso.2021.08.018_bib2","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S1470-2045(19)30794-6","article-title":"How public health services pay for radiotherapy in Europe: an ESTRO-HERO analysis on reimbursement","volume":"21","author":"Lievens","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib3","series-title":"Policy brief","article-title":"How do we ensure that innovation in health service delivery and organization is implemented, sustained and spread?","author":"Nolte","year":"2018"},{"issue":"3","key":"10.1016\/j.ejso.2021.08.018_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejca.2013.11.012","article-title":"Policy statement on multidisciplinary cancer care","volume":"50","author":"Borras","year":"2014","journal-title":"Eur J Canc"},{"issue":"4","key":"10.1016\/j.ejso.2021.08.018_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healthpol.2014.09.006","article-title":"Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes","volume":"119","author":"Prades","year":"2015","journal-title":"Health Pol"},{"key":"10.1016\/j.ejso.2021.08.018_bib6","series-title":"Pricing of cancer medicines and its impacts","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.ejso.2021.08.018_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2020.01.011","article-title":"The cost of cancer in Europe 2018","volume":"129","author":"Hofmarcher","year":"2020","journal-title":"Eur J Canc"},{"issue":"2","key":"10.1016\/j.ejso.2021.08.018_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrclinonc.2014.191","article-title":"The evolution of cancer surgery and future perspectives","volume":"12","author":"Wyld","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib9","series-title":"Engineering, and Medicine. Appropriate use of radiation oncology and surgery in oncology","year":"2016"},{"key":"10.1016\/j.ejso.2021.08.018_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejca.2017.04.014","article-title":"Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper","volume":"82","author":"Aapro","year":"2017","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2021.08.018_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.radonc.2015.04.021","article-title":"The impact of cancer incidence and stage on optimal utilization of radiotherapy: methodology of a population-based analysis by the ESTRO-HERO group","volume":"116","author":"Borras","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2015.04.018","article-title":"The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis","volume":"116","author":"Borras","year":"2015","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2021.08.018_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1470-2045(20)30589-1","article-title":"Evidence based benchmarks for use of cancer surgery in High-Income countries: a population-based analysis","volume":"22","author":"Perera Sk Jacob","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.radonc.2017.11.004","article-title":"The population benefit of evidence base radiotherapy: 5-year local control and overall survival benefits","volume":"126","author":"Hanna","year":"2018","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.08.018_bib16","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1016\/S1470-2045(18)30917-3","article-title":"Towards an evidence-informed value scale for surgical and radiation oncology: a multi-stakeholder perspective","volume":"20","author":"Lievens","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.08.018_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S026646230707033X","article-title":"Implications of learning effects for hospital costs of new health technologies: the case of intensity modulated radiation therapy","volume":"23","author":"Bonastre","year":"2007","journal-title":"Int J Technol Assess Health Care"},{"issue":"9","key":"10.1016\/j.ejso.2021.08.018_bib18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3109\/0284186X.2015.1066932","article-title":"Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technology","volume":"54","author":"Lievens","year":"2015","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2021.08.018_bib19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1080\/0284186X.2017.1348622","article-title":"Access to innovative radiotherapy: how to make it happen from an economic perspective?","volume":"56","author":"Lievens","year":"2017","journal-title":"Acta Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2021.08.018_bib20","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1080\/0284186X.2019.1639822","article-title":"Value-based health care - what does it mean for radiotherapy?","volume":"58","author":"Lievens","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib21","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/annonc\/mdv249","article-title":"A\u00a0standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology magnitude of clinical benefit scale (ESMO-MCBS)","volume":"26","author":"Cherny","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib22","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/annonc\/mdx310","article-title":"ESMO-magnitude of clinical benefit scale version 1.1","volume":"28","author":"Cherny","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib23","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2015.61.6706","article-title":"American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options","volume":"33","author":"Schnipper","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib24","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1200\/JCO.2016.68.2518","article-title":"Updating the American Society of Clinical Oncology Value framework: revisions and reflections in response to comments received","volume":"34","author":"Schnipper","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2021.05.007","article-title":"Value-based radiotherapy: a new chapter of the ESTRO-HERO project","volume":"160","author":"Lievens","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib26","series-title":"First do not harm: the report of the independent medicines and medical devices safety review","author":"Cumberledge","year":"2020"},{"key":"10.1016\/j.ejso.2021.08.018_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","article-title":"No surgical innovation without evaluation: the IDEAL recommendations","volume":"374","author":"McCulloch","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejso.2021.08.018_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/SLA.0000000000002794","article-title":"No surgical innovation without evaluation: evolution and further development of the IDEAL framework and recommendations","volume":"269","author":"Hirst","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2021.08.018_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fonc.2017.00059","article-title":"R-IDEAL: a framework for systematic clinical evaluation of technical innovations in radiation oncology","volume":"7","author":"Verkooijen","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib30","series-title":"Regulation (EU) 2017\/745 on medical devices","author":"European Parliament and Council of the European Union","year":"2017"},{"key":"10.1016\/j.ejso.2021.08.018_bib32","series-title":"Regulation (EU) 2020\/561 on medical devices","author":"European Parliament and Council of the European Union","year":"2020"},{"key":"10.1016\/j.ejso.2021.08.018_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijrobp.2016.10.042","article-title":"Promoting the appropriate use of advanced radiation technologies in oncology: summary of a National Cancer Policy Forum Workshop","volume":"97","author":"Smith","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2021.08.018_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/eurpub\/cky033","article-title":"Disinvestment in cancer care: a survey investigating European countries' opinions and views","volume":"28","author":"Specchia","year":"2018","journal-title":"Eur J Publ Health"},{"issue":"1","key":"10.1016\/j.ejso.2021.08.018_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12913-018-2941-0","article-title":"Disinvesting in health care: an overview of HTA agencies and organizations activities at European level","volume":"18","author":"Calabro","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.ejso.2021.08.018_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clon.2020.12.008","article-title":"The financial impact on reimbursement of moderately hypofractionated postoperative radiation therapy for breast cancer: an international consortium report","volume":"33","author":"Marta","year":"2021","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2021.08.018_bib37","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1002\/hec.3525","article-title":"How should hospital reimbursement be refined to support concentration of complex care services?","volume":"27","author":"Bojke","year":"2018","journal-title":"Health Econ"},{"key":"10.1016\/j.ejso.2021.08.018_bib38","series-title":"Diagnosis-Related Groups in Europe: moving towards transparency, efficiency and quality in hospitals","article-title":"Spain: a case study on diversity of DRG use\u2013The Catalan experience","author":"Cots","year":"2011"},{"key":"10.1016\/j.ejso.2021.08.018_bib39","series-title":"Payment methods for hospital stays with a large variability in the care process","author":"Stephani","year":"2018"},{"issue":"1","key":"10.1016\/j.ejso.2021.08.018_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.radonc.2017.11.005","article-title":"Adjuvant breast radiotherapy: how to trade-off cost and effectiveness?","volume":"126","author":"Morten","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib41","series-title":"Diagnosis-Related Groups in Europe: moving towards transparency, efficiency and quality in hospitals","article-title":"Moving towards transparency, efficiency and quality in hospitals: conclusions and recommendations","author":"Busse","year":"2011"},{"issue":"5","key":"10.1016\/j.ejso.2021.08.018_bib42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/SLA.0000000000002965","article-title":"Toward a consensus on centralization in surgery","volume":"268","author":"Vonlanthen","year":"2018","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2021.08.018_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195673","article-title":"What drives centralisation in cancer care?","volume":"13","author":"Kilsdonk","year":"2018","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.ejso.2021.08.018_bib44","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.healthpol.2018.08.016","article-title":"International comparison of minimum volume standards for hospitals","volume":"122","author":"Morche","year":"2018","journal-title":"Health Pol"},{"issue":"4","key":"10.1016\/j.ejso.2021.08.018_bib45","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/eurpub\/ckv237","article-title":"Improving clinical outcomes through centralization of rectal cancer surgery and clinical audit: a mixed-methods assessment","volume":"26","author":"Prades","year":"2016","journal-title":"Eur J Publ Health"},{"key":"10.1016\/j.ejso.2021.08.018_bib46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/JTO.0000000000000421","article-title":"Stereotactic body radiotherapy for lung cancer: how much does it really cost?","volume":"10","author":"Lievens","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"19","key":"10.1016\/j.ejso.2021.08.018_bib47","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2019.15888","article-title":"Alternative payment for radiation oncology","volume":"322","author":"Howard","year":"2019","journal-title":"J\u00a0Am Med Assoc"},{"issue":"11","key":"10.1016\/j.ejso.2021.08.018_bib48","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1056\/NEJMhpr1916092","article-title":"The affordable care act at 10 Years - payment and delivery system reforms","volume":"382","author":"Blumenthal","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2021.08.018_bib49","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev-publhealth-040119-094327","article-title":"The impact of Medicare's alternative payment models on the value of care","volume":"41","author":"Liao","year":"2020","journal-title":"Annu Rev Publ Health"},{"key":"10.1016\/j.ejso.2021.08.018_bib50","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S1470-2045(17)30572-7","article-title":"Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study","volume":"18","author":"Aggarwal","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2019.06.015","article-title":"National costs and resource requirements of external beam radiotherapy: a time-driven activity-based costing model from the ESTRO-HERO project","volume":"138","author":"Defourny","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.radonc.2020.01.024","article-title":"The financial impact of SBRT for oligometastatic disease: a population-level analysis in Belgium","volume":"145","author":"Nevens","year":"2020","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2021.08.018_bib53","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jtho.2016.03.010","article-title":"The state of lung cancer research","volume":"11","author":"Aggarwal","year":"2016","journal-title":"A\u00a0Global Analysis Thorac Oncol"},{"key":"10.1016\/j.ejso.2021.08.018_bib54","first-page":"389","article-title":"Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?","volume":"119","author":"Thompson","year":"2018","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ejso.2021.08.018_bib55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/1740774517725697","article-title":"Testing many treatments within a single protocol over 10 years at MRC CTU at UCL: multi-arm, multi- stage platform, umbrella and basket protocols","volume":"14","author":"Parmar","year":"2017","journal-title":"Clin Trials"},{"issue":"3","key":"10.1016\/j.ejso.2021.08.018_bib56","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2020.05.003","article-title":"Phase 2 study of stereotactic body radiation therapy for patients with oligometastatic esophageal squamous cell carcinoma","volume":"108","author":"Liu","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2021.08.018_bib57","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jval.2011.12.013","article-title":"Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework of coverage decisions","volume":"15","author":"Walker","year":"2012","journal-title":"Value Health"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321006892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321006892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:44:13Z","timestamp":1760060653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321006892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0748798321006892"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.08.018","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd. on behalf of British Association of Surgical Oncology and European Society of Surgical Oncology, and Elsevier B.V.","name":"copyright","label":"Copyright"}]}}